Cargando…

([18F])FDG Positron emission tomography with whole body magnetic resonance imaging (([18F])FDG-PET/MRI) as a diagnosis tool in Schwannomatosis

Schwannomatosis is a rare autosomal dominant genetic syndrome characterized by the presence of multiple schwannomas. The main symptom is neurogenic pain. The diagnosis requires the presence of several schwannomas and whole-body ([18F])FDG-PET/MRI might help detect extra schwannomas in patients when...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallais Sérézal, I., Ferkal, S., Lerman, L., Mulé, S., Funalot, B., Wolkenstein, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842033/
https://www.ncbi.nlm.nih.gov/pubmed/33509219
http://dx.doi.org/10.1186/s13023-021-01680-0
_version_ 1783643931619098624
author Gallais Sérézal, I.
Ferkal, S.
Lerman, L.
Mulé, S.
Funalot, B.
Wolkenstein, P.
author_facet Gallais Sérézal, I.
Ferkal, S.
Lerman, L.
Mulé, S.
Funalot, B.
Wolkenstein, P.
author_sort Gallais Sérézal, I.
collection PubMed
description Schwannomatosis is a rare autosomal dominant genetic syndrome characterized by the presence of multiple schwannomas. The main symptom is neurogenic pain. The diagnosis requires the presence of several schwannomas and whole-body ([18F])FDG-PET/MRI might help detect extra schwannomas in patients when the diagnosis is uncertain. Among the 25 patients treated for Schwannomatosis in our tertiary center, three men and two women had had a ([18F])FDG-PET/MRI performed, and the number of schwannomas detected by ([18F])FDG-PET/MRI outnumbered the number of schwannomas suspected during the clinical examination. The majority of schwannomas exhibited a radiolabeling (median of 66.7%, range 28–93%). Our findings show that ([18F])FDG-PET/MRI could prove useful when suspecting schwannomatosis to accelerate diagnosis and offer optimal care to patients.
format Online
Article
Text
id pubmed-7842033
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78420332021-01-28 ([18F])FDG Positron emission tomography with whole body magnetic resonance imaging (([18F])FDG-PET/MRI) as a diagnosis tool in Schwannomatosis Gallais Sérézal, I. Ferkal, S. Lerman, L. Mulé, S. Funalot, B. Wolkenstein, P. Orphanet J Rare Dis Letter to the Editor Schwannomatosis is a rare autosomal dominant genetic syndrome characterized by the presence of multiple schwannomas. The main symptom is neurogenic pain. The diagnosis requires the presence of several schwannomas and whole-body ([18F])FDG-PET/MRI might help detect extra schwannomas in patients when the diagnosis is uncertain. Among the 25 patients treated for Schwannomatosis in our tertiary center, three men and two women had had a ([18F])FDG-PET/MRI performed, and the number of schwannomas detected by ([18F])FDG-PET/MRI outnumbered the number of schwannomas suspected during the clinical examination. The majority of schwannomas exhibited a radiolabeling (median of 66.7%, range 28–93%). Our findings show that ([18F])FDG-PET/MRI could prove useful when suspecting schwannomatosis to accelerate diagnosis and offer optimal care to patients. BioMed Central 2021-01-28 /pmc/articles/PMC7842033/ /pubmed/33509219 http://dx.doi.org/10.1186/s13023-021-01680-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Gallais Sérézal, I.
Ferkal, S.
Lerman, L.
Mulé, S.
Funalot, B.
Wolkenstein, P.
([18F])FDG Positron emission tomography with whole body magnetic resonance imaging (([18F])FDG-PET/MRI) as a diagnosis tool in Schwannomatosis
title ([18F])FDG Positron emission tomography with whole body magnetic resonance imaging (([18F])FDG-PET/MRI) as a diagnosis tool in Schwannomatosis
title_full ([18F])FDG Positron emission tomography with whole body magnetic resonance imaging (([18F])FDG-PET/MRI) as a diagnosis tool in Schwannomatosis
title_fullStr ([18F])FDG Positron emission tomography with whole body magnetic resonance imaging (([18F])FDG-PET/MRI) as a diagnosis tool in Schwannomatosis
title_full_unstemmed ([18F])FDG Positron emission tomography with whole body magnetic resonance imaging (([18F])FDG-PET/MRI) as a diagnosis tool in Schwannomatosis
title_short ([18F])FDG Positron emission tomography with whole body magnetic resonance imaging (([18F])FDG-PET/MRI) as a diagnosis tool in Schwannomatosis
title_sort ([18f])fdg positron emission tomography with whole body magnetic resonance imaging (([18f])fdg-pet/mri) as a diagnosis tool in schwannomatosis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842033/
https://www.ncbi.nlm.nih.gov/pubmed/33509219
http://dx.doi.org/10.1186/s13023-021-01680-0
work_keys_str_mv AT gallaisserezali 18ffdgpositronemissiontomographywithwholebodymagneticresonanceimaging18ffdgpetmriasadiagnosistoolinschwannomatosis
AT ferkals 18ffdgpositronemissiontomographywithwholebodymagneticresonanceimaging18ffdgpetmriasadiagnosistoolinschwannomatosis
AT lermanl 18ffdgpositronemissiontomographywithwholebodymagneticresonanceimaging18ffdgpetmriasadiagnosistoolinschwannomatosis
AT mules 18ffdgpositronemissiontomographywithwholebodymagneticresonanceimaging18ffdgpetmriasadiagnosistoolinschwannomatosis
AT funalotb 18ffdgpositronemissiontomographywithwholebodymagneticresonanceimaging18ffdgpetmriasadiagnosistoolinschwannomatosis
AT wolkensteinp 18ffdgpositronemissiontomographywithwholebodymagneticresonanceimaging18ffdgpetmriasadiagnosistoolinschwannomatosis